News Directory

Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at


03 November 2022

Board Renewal at MTPConnect – Search for New Chair to Build Next Growth Phase

As part of its commitment to good corporate governance, MTPConnect has commenced a Board renewal process to recruit a new chair.

03 November 2022

National Diagnostic Action Plan Preliminary Findings Published

MTPConnect has been engaged by the Department of Industry, Science and Resources (DISR) to develop a National Action Plan for establishing end-to-end sovereign manufacturing capability for diagnostic products in Australia. The project is mid-way to be being delivered in partnership with Pathology Technology Australia (PTA) and supported by HTANALYSTS.

02 November 2022

MTPConnect podcast: CSIRO Kick-Starts R&D for Start-ups like Singular Health to Commercialise Innovations

Five years on, CSIRO’s Kick-Start program continues to support early-stage start-ups and small businesses facing barriers through R&D support. Over 200 companies have benefited from Kick-Start support by having access to CSIRO’s research and capability through an innovative voucher scheme.

31 October 2022

Vast Bioscience – solving the growing post-surgical pain conundrum with 3D Drug Discovery Technology

Pain is a debilitating condition and over the past few decades, escalating use of opioid therapeutics to manage pain has become a cause of concern in many countries, including Australia. Brisbane-based biotech company Vast Bioscience Pty Ltd aims to offer the pharmaceutical industry a unique opportunity to develop innovative drugs with superior potency, target selectivity and safety to help treat pain.

28 October 2022

Team Australia Wraps Up the MedTech Conference in Boston

The MTPConnect team and the 18 companies in the Australian delegation are wrapping up a week of activities at the 2022 MedTech Conference in Boston. Check out some of the top level opportunities that MTPConnect organised for these promising medtech companies.

26 October 2022

REDI Fellow Explores AI’s Powerful Role in Pathology

In Associate Professor Ewan Millar’s vision for the future of pathology in NSW, the skills, experience and expertise of Anatomical Pathologists is backed by powerful technology. A/Prof. Millar from NSW Health Pathology is currently undertaking a REDI Fellowship with Paige, a New York based global leader in AI-based diagnostic pathology software. Read about his work with Paige and his REDI Fellowship experience - an unrivalled opportunity and his dream role.

26 October 2022

MTPConnect cements US medtech links through MoU with influential Medical Alley Association at the 2022 MedTech Conference

MTPConnect and the Medical Alley Association of Minnesota have committed to working closely together to support the growth of medtech companies with the signing today of a Memorandum of Understanding. The MoU was signed at the 2022 MedTech Conference in Boston by MTPConnect Chief Executive Officer Stuart Dignam and Medical Alley Association’s Vice President of Intelligence, Frank Jaskulke.

25 October 2022

New funding for The Bridge Program to continue its successful pharma commercialisation training in 2023

The Bridge Program is proud to announce that MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative will be the new sponsor of its successful Australian pharmaceutical commercialisation training program delivered by Queensland University of Technology (QUT).

25 October 2022

Apply for GSK Australia’s Graduate Researcher Program!

The GSK Australia Graduate Researcher Program is an Australian government funded, industry-hosted initiative developed to help bridge the skills gap between academia and the pharmaceutical industry. The program aims to provide participants with a diverse range of development opportunities, hands-on experiences, and exposure, with a view to improving Australia’s success, capacity, and capability in terms of the translation and commercialisation of health and medical research. Find out more and apply for GSK's 2023 intake!

25 October 2022

Australia’s Delegation to the MedTech Conference Hits Washington and Boston

As thousands in the medical technology sector descend on Boston for the start of this week’s MedTech 2022 Conference, MTPConnect’s Australian delegation made a pre-conference visit to JLABS @ Washington, DC and joined together for a special welcome networking reception over the weekend.

21 October 2022

MTPConnect’s TTRA program invests $6.7 million to accelerate transformative Australian diabetes and cardiovascular disease innovations

MTPConnect and the Minister for Health and Aged Care, The Hon. Mark Butler MP, today announced $6.7 million funding for nine diabetes and cardiovascular disease research projects through the Targeted Translation Research Accelerator (TTRA) program.

21 October 2022

MTPConnect’s CTCM program invests $7.2 million to accelerate medical device innovations

MTPConnect and the Minister for Health and Aged Care, The Hon. Mark Butler MP, today announced $7.2 million of funding for five cutting edge medical technology projects through the Clinical Translation and Commercialisation Medtech (CTCM) program.

20 October 2022

Atmo Biosciences gas-sensing tech aims to provide user-friendly diagnostic solution for gut disorders

In 2020, gut health medtech Atmo Biosciences set out to demonstrate proof-of-concept for its gas-sensing technology – the Atmo Gas Capsule System – supported by funding from MTPConnect’s BioMedTech Horizons program.